Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination.

Article Details

Citation

Copy to clipboard

Kyei S, Nketsiah AA, Asiedu K, Awuah A, Owusu-Ansah A

Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination.

Afr Health Sci. 2017 Sep;17(3):923-932. doi: 10.4314/ahs.v17i3.36.

PubMed ID

29085421 [ View in PubMed

]

Abstract

PURPOSE: To study the time course (onset, time and duration of maximal cycloplegia, and the full duration) of cycloplegic action of 1% Cyclopentolate - 1% Tropicamide. METHODS: Seventy-seven students, aged 15-24 years were purposively sampled from the University of Cape Coast and Cape Coast Technical Institute. Subjective near addition (ADD) determination and pupil diameter measurement before and after a drop of the test agent (1% Cyclopentolate - 1% Tropicamide combination in the right eye) and the control (1% Cyclopentolate in the left eye) were performed. Measurements of subjective near ADD and pupil diameter were made after the initial reading at 5 minutes interval for the first hour and every 30 minutes for the next 7 hours for each participant. Time of onset, time of peak cycloplegia, duration of peak cycloplegia and duration of total cycloplegic effect was indirectly determined. RESULTS: 1% Cyclopentolate - 1% Tropicamide combination had rapid onset of cycloplegia (5-10 minutes), shorter time of maximal cycloplegia (55 versus 90 minutes), and recovery (7 versus >/= 8hours) in the majority (79.2%) of subjects. CONCLUSION: Cyclopentolate -Tropicamide combination was comparable to Cyclopentolate in depth of cycloplegia produced, and clinically superior to 1% Cyclopentolate in rapidity of cycloplegic onset, time of maximal cycloplegia and recovery from cycloplegia.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Cyclopentolate	Muscarinic acetylcholine receptor M1	Protein	Humans	Yes	Antagonist	Details